What is the fair value of Pulmonx Corp (NASDAQ-LUNG) stock?

The current fair value estimate for Pulmonx Corp (NASDAQ-LUNG) is $2.42. This implies an estimated upside of 85.8% versus the current market price.

Is Pulmonx Corp (NASDAQ-LUNG) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 85.8% versus the current market price.

What is the analyst price target for NASDAQ-LUNG stock?

The available analyst price target for Pulmonx Corp (NASDAQ-LUNG) is $3.40. The analyst target implies estimated upside of 161.5%.

How is the financial health of Pulmonx Corp?

The current financial health read for Pulmonx Corp (NASDAQ-LUNG) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Pulmonx Corp's next earnings date?

The next earnings date currently listed for Pulmonx Corp (NASDAQ-LUNG) is July 29, 2026.

Does Pulmonx Corp (NASDAQ-LUNG) pay dividends?

Based on the current data, dividend yield is 0.0%.

What is the P/E ratio for Pulmonx Corp (NASDAQ-LUNG)?

The current P/E ratio listed for Pulmonx Corp (NASDAQ-LUNG) is -1.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Pulmonx Corp?

The current market capitalization listed for Pulmonx Corp is 57.231 M.

What is the enterprise value of Pulmonx Corp?

The current enterprise value listed for Pulmonx Corp is 49.207 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Pulmonx Corp?

The ticker symbol for Pulmonx Corp is NASDAQ-LUNG, and the stock is listed on NASDAQ.

Where is Pulmonx Corp (NASDAQ-LUNG) listed?

Pulmonx Corp (NASDAQ-LUNG) is listed on NASDAQ.

What is the debt-to-total-capital ratio for Pulmonx Corp?

The current debt-to-total-capital ratio listed for Pulmonx Corp is 49.5%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Pulmonx Corp?

The free float listed for Pulmonx Corp is 87.5%. Free float helps investors understand how much of the share base is available for public trading.

Pulmonx Corp (LUNG) Fair Value & Stock Analysis

Pulmonx Corp (LUNG)

Pulmonx Corporation is a commercial-stage medical technology company focused on minimally invasive treatment options for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its product portfolio includes the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System, and the LungTraX Platform. LungTraX is a cloud-based quantitative CT analysis service that includes tools such as LungTraX Connect, LungTraX Detect, and StratX Lung report, which support physician workflow and help evaluate patients for treatment. The company serves patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and other international markets. Pulmonx was incorporated in 1995 and is headquartered in Redwood City, California. Its common stock is listed on NASDAQ under the symbol LUNG.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NASDAQ-LUNG	$2.42	85.8% Upside	Bargain	$3.40	161.5% Upside	Bargain	Fair	—	—	—	0.0%	July 29, 2026	-1.0x	1.2x	0.6x	57.231 M	49.207 M	49.5%	87.5%	-5.9	—	55.3%

Send a message